Suppr超能文献

小儿腭裂修复术后加速康复:系统评价和荟萃分析。

Enhanced Recovery After Surgery for Pediatric Cleft Repair: A Systematic Review and Meta-Analysis.

机构信息

Perelman School of Medicine.

Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia, PA.

出版信息

J Craniofac Surg. 2022 Sep 1;33(6):1709-1713. doi: 10.1097/SCS.0000000000008544. Epub 2022 Feb 7.

Abstract

OBJECTIVE

Perform a systematic review assessing the efficacy of enhanced recovery after surgery (ERAS) protocols for cleft palate repair. Primary outcomes included hospital length of stay, readmission rates, and postoperative narcotic use. Secondary outcomes included complications, time to initial postoperative oral intake, and pain scores.

DATA SOURCES

Cohort and randomized studies of ERAS protocols pertaining to cleft palate repair were identified by systematic review of Medline, Scopus, Embase, and grey literature.

REVIEW METHODS

Data extracted included patient demographics, clinical care protocols, complication rates, postoperative narcotic use, time to initial postoperative oral intake, hospital length of stay, family satisfaction, and 30-day readmission. Meta-analysis was used to compare outcomes between patients enrolled in ERAS protocols versus those in conventional care pathways.

RESULTS

Eight hundred sixty-five articles were screened, and 5 studies met full inclusion criteria. A total of 425 patients were included. Patients in ERAS protocols saw a mean reduction of - 23.96 hours in length of stay compared to controls (95% confidence interval [CI]: - 26.4, - 20.6). Patients in ERAS protocols also had decreased total morphine consumption (mean difference [MD]: - 3.88 mg; CI: - 4.31, - 3.45), and decreased time to first initial feed compared to controls (MD: - 3.88 hours; CI: - 4.3, - 3.5). There was no difference in readmission rates or complication rates between ERAS and control groups.

CONCLUSIONS

ERAS protocols have seen limited use in pediatric patients. The present study sought to assess the impact of ERAS protocols following primary palatoplasty. Our results indicate decreased hospital length of stay, postoperative opioid consumption, and time to feeding, without increasing readmission rates or complication rates.

摘要

目的

系统评价评估增强术后康复(ERAS)方案治疗腭裂修复的疗效。主要结局包括住院时间、再入院率和术后阿片类药物使用。次要结局包括并发症、首次术后口服摄入时间和疼痛评分。

数据来源

通过系统评价 Medline、Scopus、Embase 和灰色文献,确定了与腭裂修复相关的 ERAS 方案的队列和随机研究。

审查方法

提取的数据包括患者人口统计学、临床护理方案、并发症发生率、术后阿片类药物使用、首次术后口服摄入时间、住院时间、家庭满意度和 30 天再入院率。Meta 分析用于比较接受 ERAS 方案和常规护理路径的患者的结局。

结果

筛选出 865 篇文章,其中 5 项研究符合全部纳入标准。共有 425 名患者纳入研究。与对照组相比,ERAS 方案组的患者平均住院时间减少了-23.96 小时(95%置信区间[CI]:-26.4,-20.6)。ERAS 方案组患者的总吗啡消耗量也减少(平均差值[MD]:-3.88mg;CI:-4.31,-3.45),首次初始喂养时间也比对照组缩短(MD:-3.88 小时;CI:-4.3,-3.5)。ERAS 组和对照组的再入院率或并发症率无差异。

结论

ERAS 方案在儿科患者中的应用有限。本研究旨在评估 ERAS 方案在初次腭裂修复后的影响。我们的研究结果表明,ERAS 方案可缩短住院时间、减少术后阿片类药物使用量和喂养时间,而不会增加再入院率或并发症率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验